ReviewAmerican journal of cancer research2026

Metabolic reprogramming in diabetes and cancer: the role of PI3K/AKT/mTOR and beyond.

Nahed S AlharthiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.